Drugs / Sargamostatim
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03123666 | Apr 2017 → Oct 2020 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sargamostatim | “Patients who fulfil the inclusion criteria will receive either slow IV infusion of GM CSF (Sargamostatim-250mcg/M2) over 4 hour and inhalation of same dose by micronebulizer...” NCT03123666 ↗ |
| Known as | GM CSF | “GM CSF (Sargamostatim-250mcg/M2) over 4 hour and inhalation of same dose by micronebulizer” NCT03123666 ↗ |
| Route | Intravenous | “slow IV infusion” NCT03123666 ↗ |